Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
MIKA.JK
Strong BuyPremium GrowerPT Mitra Keluarga Karyasehat Tbk · Healthcare · Indonesia · $1.5B · Avg Vol: $480K/d
COMPANY DESCRIPTION
PT Mitra Keluarga Karyasehat Tbk, together with its subsidiaries, owns and operates hospitals in Indonesia. The company also offers healthcare platform services.
FINANCIAL SUMMARY (IDR)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.0T | 4.3T | 4.9T | 5.4T | 9.9% | 5.6T | 5.9T | 6.6T | 10.8% |
| EPS (IDR) | 71.61 | 65.08 | 82.43 | 98.13 | 11.1% | 101.38 | 103.57 | 119.89 | 10.5% |
| Shares | 13.9B | 13.9B | 13.9B | 13.9B | 0.0% | 13.9B | — | — | — |
| Debt | 0 | 3.1B | 1.6B | 9.6B | 76.8% | 9.3B | — | — | — |
| Equity | 5.4T | 5.8T | 6.5T | 7.3T | 10.2% | — | — | — | — |
| Op CF | 1.1T | 1.3T | 1.7T | 1.9T | 19.5% | 2.1T | — | — | — |
| Inv CF | -840.3B | -637.1B | -998.3B | 153.6B | — | — | — | — | — |
| Fin CF | -880.9B | -530.3B | -505.8B | -615.6B | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of MIKA.JK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| MIKA.JK | PT Mitra Keluarga Karyasehat Tbk(you) | $1.5B | 84 | Strong Buy |
| SILO.JK | PT Siloam International Hospitals Tbk | $1.6B | 78 | Buy |
| HEAL.JK | PT Medikaloka Hermina Tbk | $589M | 35 | Sell |
| SAME.JK | PT Sarana Meditama Metropolitan Tbk | $308M | 46 | Hold |
| LPKR.JK | PT Lippo Karawaci Tbk | $249M | 40 | Hold |
| SRAJ.JK | PT Sejahteraraya Anugrahjaya Tbk | $9.2B | 13 | Strong Sell |
| KLBF.JK | PT Kalbe Farma Tbk. | $2.0B | 94 | Strong Buy |
| SOHO.JK | PT Soho Global Health Tbk | $1.2B | 57 | Hold |
| MARK.JK | PT Mark Dynamics Indonesia Tbk | $233M | 100 | Strong Buy |
| PRDA.JK | PT Prodia Widyahusada Tbk | $142M | 100 | Strong Buy |
Peer medians: ROE 7.3% · P/E 17.0x · Gross margin 35.8%